Recent Quotes (30 days)

You have no recent quotes
chg | %

ImmunoVaccine Inc.  

(Public, CVE:IMV)   Watch this stock  
Find more results for IMV
+0.050 (5.88%)
Apr 17 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.85 - 0.90
52 week 0.22 - 1.50
Open 0.85
Vol / Avg. 87,700.00/117,073.00
Mkt cap 71.54M
P/E     -
Div/yield     -
EPS -0.08
Shares 79.49M
Beta 4.12
Inst. own     -
Feb 10, 2014
IMMUNO VACCINE INC at Biotechnology Industry Organization CEO & Investor Conference

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -208.23% -116.45%
Return on average equity -4369.47% -186.56%
Employees 21 -
CDP Score - -


Suite 412, 1344 Summer Street
+1-902-4921819 (Phone)
+1-902-4920888 (Fax)

Website links


Immunovaccine Inc. is a clinical stage vaccine development company. The Company is focusing its research and development on developing an early stage human health vaccine pipeline consisting of infectious diseases and therapeutic cancer vaccine products. The Company�s advanced vaccine candidate is DPX-0907, a multivalent therapeutic cancer vaccine targeting ovarian, breast and prostate cancers. During the year ended December 31, 2010, the Company was in a multi-site Phase I human clinical trial for DPX-0907 in the United States. The Company has developed a lipid depot-based vaccine delivery and enhancement technology called the DepoVax platform, an improvement on the Company�s original VacciMax platform. The Company has completed proof of concept pre-clinical studies in infectious disease applications, such as single-dose DepoVax platform-based pandemic influenza and hepatitis B vaccine candidates.

Officers and directors

Albert James Scardino Executive Chairman of the Board
Age: 65
John J. Trizzino Chief Executive Officer, Director
Age: 51
Kimberly Stephens Chief Financial Officer
Marc Mansour Ph.D. Chief Operating Officer, Director
Age: 39
Vicki Morgan Vice President - Business Development
Llew Keltner M.D., Ph.D. Director
Age: 63
Stephanie M. Leouzon Director
Wade K. Dawe Independent Director
James W. Hall Independent Director
Age: 64
Wayne F. Pisano Independent Director